$47.4 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
-Total revenue in the last quarter.
-Net income is all revenues minus all expenses including taxes and interest in the last quarter.
$4.71Earnings per share is the amount of net income that is attributed to each single share outstanding.
-Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
68.63xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
-Earnings before interest expenses and taxes in the last quarter.
7,700The number of full time employees.
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
Shares of cancer screening and diagnostics company EXACT Sciences Corporation (NASDAQ: EXAS ) were rallying to a record high Tuesday after it announced two M&A transactions and third-quarter result...Benzinga, 2 days ago
Illumina, Inc. (NASDAQ:ILMN) Director Jay T. Flatley sold 4,000 shares of Illumina stock in a transaction that occurred on Tuesday, October 20th. The stock was sold at an average price of $321.72, ...Daily Political, 5 days ago
Illumina (NASDAQ:ILMN) was downgraded by equities research analysts at BidaskClub from a “buy” rating to a “hold” rating in a report issued on Tuesday, BidAskClub reports. ILMN has been the topic o...Transcript Daily, 7 days ago